About this trial
The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are:
Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task?
Participants will:
Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Clients with AMD, DR or Glaucoma
Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.
Disqualifiers
Clients with other age related eye diseases other than AMD, DR or Glaucoma.
Clients who do not wish to participate in this study.
Trial design
Single group
Treatments tested in this trial
occupational therapy interventions for low vision care
Combination productOccupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.
Treatment groups
Trial outcomes
Primary outcomes
Revised Self Report Assessment of Functional Visual
A standardized assessment which provides information on how well adults with vision loss can perform daily tasks. This tool has 33 assessment components and a higher score indicates less functional impairment. A lower score indicates a higher impairment.
MediCog Screening Tool
The Medi-Cog has a maximum score of 10 points, and a score of 7 or lower may indicate cognitive impairment.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.